GEMBIN 200MG INJECTION

GEMBIN 200MG INJECTION disrupts the growth of cancer cells by blocking the production and repair of DNA, ultimately leading to cell death and inhibiting tumor growth.

GEMBIN 200MG INJECTION exerts its anticancer effects through a multi-step process. Once inside the body, it is converted into its active form, GEMBIN 200MG INJECTION triphosphate. GEMBIN 200MG INJECTION triphosphate is then incorporated into the growing DNA chain during DNA replication, leading to chain termination and DNA strand breakage. Additionally, GEMBIN 200MG INJECTION inhibits the enzyme ribonucleotide reductase, which is responsible for the production of deoxyribonucleotides required for DNA synthesis. By blocking this enzyme, GEMBIN 200MG INJECTION limits the availability of building blocks necessary for DNA replication. Furthermore, GEMBIN 200MG INJECTION inhibits the repair of DNA damage by interfering with the activity of enzymes involved in DNA repair pathways. The cumulative effect of these actions is the disruption of cancer cell growth and division, leading to cell death. GEMBIN 200MG INJECTION is most effective against rapidly dividing cells, such as cancer cells, but it may also affect normal cells that undergo rapid proliferation, such as bone marrow cells, hair follicle cells, and cells lining the gastrointestinal tract.